Pharming Group N.V. Stock 12‑Month Price Target Raised to $32.69, Implies 137% Upside

• According to estimates from 5 analysts, Pharming Group N.V. stock's average price target has risen from $31.09 to $32.69, with forecasts ranging from $20.6 to $40 per share
• Based on the Jul. 2 closing price, the updated target implies approximately 137% potential upside
• Consensus rating remains at “Buy” across 5 covering analysts, with 5 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for Pharming Group N.V. on the , and track all previous and future analyst recommendations for Pharming Group N.V. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.